Antibacterial potential of Thymus linearis essential oil collected from Wasturwan mountain: A combination of experimental and theoretical studies involving in silico molecular docking simulation of the major compounds against Novobiocin-resistant mutant of DNA Gyrase-B.

Autor: Firdous S; Department of Chemistry, Islamic University of Science and Technology, Awantipora, 192122, Jammu and Kashmir, India., Bhat SH; Watson-Crick Centre for Molecular Medicine, Islamic University of Science and Technology, Awantipora, 192122, Jammu and Kashmir, India., Aziz S; Department of Chemistry, Islamic University of Science and Technology, Awantipora, 192122, Jammu and Kashmir, India., Jehangir M; Department of Chemistry, Islamic University of Science and Technology, Awantipora, 192122, Jammu and Kashmir, India., Syeed S; Watson-Crick Centre for Molecular Medicine, Islamic University of Science and Technology, Awantipora, 192122, Jammu and Kashmir, India., Iqra Z; CSIR Indian Institute of Integrative Medicine, Field Station, Pulwama, 192301, India., Ahmad MA; Watson-Crick Centre for Molecular Medicine, Islamic University of Science and Technology, Awantipora, 192122, Jammu and Kashmir, India., Rasool S; CSIR Indian Institute of Integrative Medicine, Field Station, Pulwama, 192301, India., Khursheed A; CSIR Indian Institute of Integrative Medicine, Field Station, Pulwama, 192301, India., Shalla AH; Department of Chemistry, Islamic University of Science and Technology, Awantipora, 192122, Jammu and Kashmir, India., Ganaie AA; Watson-Crick Centre for Molecular Medicine, Islamic University of Science and Technology, Awantipora, 192122, Jammu and Kashmir, India; Centre for AYUSH Sciences, Islamic University of Science and Technology, Awantipora, 192122, Jammu and Kashmir, India. Electronic address: arsheed.ganaie@gmail.com., Rather MA; Department of Chemistry, Islamic University of Science and Technology, Awantipora, 192122, Jammu and Kashmir, India. Electronic address: manzooriiim@gmail.com.

Publikováno v: Microbial pathogenesis [Microb Pathog] 2023 Oct; Vol. 183, pp. 106280. Date of Electronic Publication: 2023 Aug 02.

Anti-S100A4 Antibody Therapy Is Efficient in Treating Aggressive Prostate Cancer and Reversing Immunosuppression: Serum and Biopsy S100A4 as a Clinical Predictor.

Autor: Ganaie AA; Department of Urology, Medical School, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Mansini AP; Department of Urology, Medical School, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Hussain T; Department of Urology, Medical School, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Rao A; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, Minnesota., Siddique HR; Department of Urology, Medical School, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.; Department of Zoology, Aligarh Muslim University, Aligarh, Uttar Pradesh, India., Shabaneh A; Institute for Health Informatics, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Ferrari MG; Department of Urology, Medical School, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Murugan P; Department of Laboratory Medicine and Pathology, Medical School, University of Minnesota, Minneapolis, Minnesota., Klingelhöfer J; Danish Cancer Society Research Center, Copenhagen, Denmark.; Laboratory of Neural Plasticity, Copenhagen University, Copenhagen, Denmark., Wang J; Institute for Health Informatics, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Ambartsumian N; Danish Cancer Society Research Center, Copenhagen, Denmark.; Laboratory of Neural Plasticity, Copenhagen University, Copenhagen, Denmark., Warlick CA; Department of Urology, Medical School, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Konety BR; Department of Urology, Medical School, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.; Rush Medical College, Rush University, Chicago, Illinois., Saleem M; Department of Urology, Medical School, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota. msbhat@umn.edu.

Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2020 Dec; Vol. 19 (12), pp. 2598-2611. Date of Electronic Publication: 2020 Sep 30.

A novel terpenoid class for prevention and treatment of KRAS-driven cancers: Comprehensive analysis using in situ, in vitro, and in vivo model systems.

Autor: Ganaie AA; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Siddique HR; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.; Department of Zoology, Aligarh Muslim University, Aligarh, Uttar Pradesh, India., Sheikh IA; King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia., Parray A; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.; Academic Health Systems Hamad Medical Corporation, Doha, Qatar., Wang L; Hormel Institute, University of Minnesota, Austin, Minnesota., Panyam J; School of Pharmacy, University of Minnesota, Minneapolis, Minnesota., Villalta PW; Analytical Chemistry Core, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Deng Y; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Konety BR; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Saleem M; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.

Publikováno v: Molecular carcinogenesis [Mol Carcinog] 2020 Aug; Vol. 59 (8), pp. 886-896. Date of Electronic Publication: 2020 Apr 15.

Characterization of Novel Murine and Human PDAC Cell Models: Identifying the Role of Intestine Specific Homeobox Gene ISX in Hypoxia and Disease Progression.

Autor: Ganaie AA; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Parray A; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, MN; Translational Research Institute, Academic Health Systems Hamad Medical Corporation, Doha, Qatar., Hussain T; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, MN; MD Anderson Cancer Center, Science Park, Smithville, TX., Shabaneh A; Institute for Health Informatics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Jamroze A; Hormel Institute, University of Minnesota, Austin, MN., Ferrari MG; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Wang L; Department of Cancer Genetics, Hormel Institute, University of Minnesota, Austin, MN., Liao DJ; Department of Cancer Genetics, Hormel Institute, University of Minnesota, Austin, MN., Koochekpour S; Department of Urology, University of Florida, Jacksonville, Florida., Nanda S; Department of General Internal Medicine, Mayo Clinic, Rochester, MN., Wang J; Institute for Health Informatics, Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Deng Y; Department of Cancer Genetics, Hormel Institute, University of Minnesota, Austin, MN., Gradilone SA; Cancer Cell Biology and Translational Research Section, Hormel Institute, University of Minnesota, Austin, MN., Hinchcliffe EH; Cellular Dynamics Section, The Hormel Institute, University of Minnesota., Konety BR; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Saleem M; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, MN. Electronic address: msbhat@umn.edu.

Publikováno v: Translational oncology [Transl Oncol] 2019 Aug; Vol. 12 (8), pp. 1056-1071. Date of Electronic Publication: 2019 Jun 04.

BMI1 Drives Metastasis of Prostate Cancer in Caucasian and African-American Men and Is A Potential Therapeutic Target: Hypothesis Tested in Race-specific Models.

Autor: Ganaie AA; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Beigh FH; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Astone M; Department of Molecular Biology and Translational Cancer Research, Hormel Institute, Austin, Minnesota., Ferrari MG; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Maqbool R; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Umbreen S; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Parray AS; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.; Institute of Neurosciences, Academic Health Systems Hamad Medical Corporation, Doha, Qatar., Siddique HR; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.; Aligarh University, Aligarh, Uttar Pradesh, India., Hussain T; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Murugan P; Department of Lab Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota., Morrissey C; Department of Urology, University of Washington, Seattle, Washington., Koochekpour S; Department of Cancer Genetics and Genomics, Roswell Park Cancer Center, Buffalo, New York., Deng Y; Department of Mouse Genetics, Hormel Institute, Austin, Minnesota., Konety BR; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota., Hoeppner LH; Department of Molecular Biology and Translational Cancer Research, Hormel Institute, Austin, Minnesota., Saleem M; Department of Urology, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota. msbhat@umn.edu.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Dec 15; Vol. 24 (24), pp. 6421-6432. Date of Electronic Publication: 2018 Aug 07.